In this special episode, The Oncology Brothers focus on the center of personalized medicine: the patient. Patient advocate and lung cancer survivor Jill Feldman details her lung cancer journey, from early-stage disease to advanced stage with metastases. Jill, who is a co-founder of the EGFR Resisters, an advocacy group that aims to improve outcomes for people with EGFR-positive lung cancer, speaks about how novel therapies have provided her with the opportunity to live out her life and spend quality time with loved ones.